Skip to content
Home/Companies/Biotech/Orchard Therapeutics
OT

Orchard Therapeutics

Biotech·UK·Exited 2018·Held 1yr

Orchard Therapeutics is a biotech company, headquartered in UK.

Entry
2017
Hold
1yr
Exit
2018
Est. EV
–

Who owns Orchard Therapeutics?

Orchard Therapeutics was owned by 4Bio Partners through 4BIO Ventures III (2022 vintage) from 2017 to 2018, exited via IPO.

Hand-verified · updated 2026-07-08

4Bio Partners
Investor
4Bio Partners
4BIO Ventures III · 2022 · Life Sciences VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2018

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics
Active
BiotechUK· 2026
Actithera
Active
BiotechSwitzerland· 2025
Hornet Therapeutics
Active
BiotechUK· 2024
March Biosciences
Active
BiotechUS· 2024
Ascend Advanced Therapies
Active
BiotechUK· 2023
Trogenix
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings